We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
98 hedge funds and large institutions have $161M invested in Corcept Therapeutics in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,804% more call options, than puts
Call options by funds: $476K | Put options by funds: $25K
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more funds holding
Funds holding: 80 → 98 (+18)
3% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 29
34% less capital invested
Capital invested by funds: $244M → $161M (-$83M)
Holders
98
Holders Change
+18
Holders Change %
+22.5%
% of All Funds
2.74%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
24
Increased
30
Reduced
29
Closed
6
Calls
$476K
Puts
$25K
Net Calls
+$451K
Net Calls Change
-$2.02M
Top Buyers
| 1 |
ISL
Ingalls & Snyder LLC
New York
|
+$2.38M |
| 2 |
Morgan Stanley
New York
|
+$2.04M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.96M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$1.7M |
| 5 |
Millennium Management
New York
|
+$990K |
